LyGenesis Secures Approval to Advance Phase 2a Clinical Trial for Liver Regeneration LyGenesis, Inc. has received the go-ahead for its Phase 2a clinical trial from the Data and Safety Monitoring Board, marking a significant milestone for organ regeneration research.

LyGenesis Secures Approval to Advance Phase 2a Clinical Trial for Liver Regeneration #United_States #Pittsburgh #Clinical_Trial #LyGenesis #organ_regeneration